Table 2.
Drug name | Drug types | Roles | LEN resistance | Reference |
---|---|---|---|---|
Elacridar | ABCB1 and BCRP inhibitor | Inhibition of ABCB1 and BCRP | Inhibition | [354] |
Flubendazole | Anthelmintic | Inhibition of PCSK9 and hedgehog signaling | Inhibition | [276] |
Losartan | AT-II receptor blocker | Suppressing VEGF-A expression | Inhibition | [348] |
Secukinumab | Biologic agent targeting IL-17A | Inhibition of BCL2 expression and promotion of autophagy pathway | Inhibition | [231] |
Palbociclib | CDK4/6 inhibitor | Inhibition of wnt/β-catenin signaling | Inhibition | [257] |
Abemaciclib | Chinese herbal extracts | Inhibition of c-MYC | Inhibition | [350] |
Amentoflavone | Inhibition of AKT/ERK signaling | Inhibition | [183] | |
Sophoridine | Inhibition of VEGFR2 and MAPK/ERK signaling | Inhibition | [185] | |
OSC | Inhibition of FGFR1, AKT/mTOR and MAPK/ERK signaling | Inhibition | [187] | |
Betulin | Inhibition of the mTOR/IL-1β signaling | Inhibition | [240] | |
CP | Inhibition of exosome-mediated autophagy | Inhibition | [233] | |
Curcumin | Inhibition of EGFR and PI3K/AKT signaling | Inhibition | [207] | |
Dasatinib | c-SRC inhibitor | Inhibition of c-SRC | Inhibition | [351] |
Erlotinib | EGFR inhibitor | Inhibit of STAT/ABCB1 axis and inhibition of LEN exocytosis | Inhibition | [355] |
GANT61 | GLI1/2 inhibitor | Inhibition of hedgehog signaling | Inhibition | [273] |
Simvastatin | HMG CoA Reductase inhibitor | Inhibition of cholesterol synthesis and hedgehog signaling | Inhibition | [282] |
Metformin | Hypoglycemic drug | Inhibition of AKT signaling | Inhibition | [203] |
Metformin | Inhibition of wnt/β-catenin signaling | Inhibition | [256] | |
BAFA1 | Macrolide antibiotics | Inhibit autophagic degradation of NRP1 | Promotion | [222] |
Aspirin | NSAIDs | Downregulation of AKT and MAPK/ERK signaling | Inhibition | [357] |
Celecoxib | Decrease the survival rate of PD-L1 neutrophils | Inhibition | [358] | |
Vitamin C | Vitamins | / | Inhibition | [349] |
Abbreviations: ABCB1: ATP binding cassette subfamily B member 1; BCRP: Breast cancer resistance protein; PCSK9: Proprotein convertase subtilisin/kexin type 9; BCL2: B-cell lymphoma 2; OSC: Oxysophocarpine; CP: Compound phyllanthus urinaria; BAFA1: Bafilomycin A1; NSAIDs: Non-steroidal anti-inflammatory drugs.